A recent observation might disprove this in BCCs, since we observed in BCCs regressed during oral treatment with an inhibitor of the smo/gli pathway that in absence of tumor cells, the vessel-containing tumor bed was still present (data not shown). The gene discussed is GLI1; the disease is neoplasm.